PSMA-PET Imaging for Prostate Cancer: Recent Advances and Key Updates

home / viewpoints / psma-pet-imaging-for-prostate-cancer-recent-advances-and-key-updates

A panel of experts discuss recent advances and key updates on the use of PSMA-targeted PET imaging in patients with prostate cancer.

Michael Cookson, MD, MMHC, explains the NCCN criteria used to stratify patients with clinically localized prostate cancer into risk groups.

Scott Sellinger, MD, FACS, shares a historical perspective on use of conventional imaging modalities in prostate cancer.

Contact Info

2 Clarke Drive
Cranbury, NJ 08512